On the occasion of Professor Imming's upcoming retirement, the Institute of Pharmacy organized a farewell symposium on January 24, 2025 under the title „What Pharmacists Can Become.“ Former companions and doctoral students of Professor Imming were invited as speakers, who presented their professional development and their current field of activity as pharmacists. Career paths in the pharmaceutical industry and academic research were discussed, as were the professional activities of pharmacists in public pharmacies or in the Bundeswehr. The broad spectrum of speakers also made it possible to look back at Professor Imming's work as a university lecturer and pharmaceutical chemist, who has always shown great commitment to young scientists and teaching in pharmacy studies.

Prof. Dr. Sonja Keßler received the Phoenix Pharmacy Science Prize 2024 in the Pharmacology and Clinical Pharmacy category. She was honored for her research into the question of why some colon cancer patients develop resistance to common chemotherapy drugs. The prize is endowed with 10,000 euros per category and is awarded by the pharmaceutical wholesaler “Phoenix group”.

https://www.campus- halensis.de/artikel/phoenix/

The Institute of Pharmacy is inviting to the lecture series on "Pharmaceutical knowledge in past and present", which is organized by Prof. Dr. Imming. The lectures will be held in German language. For details see the following flyer:

Flyer lecture series

www.nature.com/articles/s41586-023-06878-9 ->

Dr. Adrian Richter's DFG application “Development of phenylalaninamides and piperidine-4-carboxamides with antibacterial effects against resistant mycobacteria - synthetic derivatization, antimycobacterial testing and pharmacokinetic characterization” was approved and, in addition to material resources, includes a postdoc position for himself and a doctoral position. Dr. Richter will collaborate with Prof. Elizabeth Campbell (The Rockefeller University, New York), Prof. Thomas Dick (Drug Discovery Center, Hackensack Meridian, Nutley) and Prof. Ludger Wessjohann (Leibniz Institute for Plant Biochemistry, Halle).

Structural surfaceomics reveals an AML-specific conformation of integrin ß2 as a CAR T cellular therapy target - PubMed ->

The federal state of Saxony-Anhalt annually awards the Hugo Junkers Prize for pioneering innovations from science, industry and crafts. The first prize, endowed with 10,000 euros, in the category “Most Innovative Projects in Basic Research” This year, an interdisciplinary team from Martin Luther University from pharmacy and university medicine won with the project “Hydrogel-forming nanofibers– a new option for ocular drug therapy”. The pharmaceutical technologists Prof. Dr. Karsten Mäder and Dr. Benedikt Göttel developed together with Prof. Dr. Arne Viestenz and Dr. Joana Heinzelmann from the University Hospital and Polyclinic for Ophthalmology developed novel fleeces made of nanofibers with adapted geometry for application to the eye. In contrast to eye drops, the fleeces lead to 100% absorption of the applied dose into the tear fluid and, due to in-situ hydrogel formation, to a longer retention time. In addition, using the manufacturing technology developed, the researchers were able to develop a highly effective and better-tolerated formulation for the problematic drug amphotericin B, so that more effective treatment of fungal eye infections is possible.

From May 30th until July 4, 2023, Prof. Dr. Courtney Aldrich from the School of Pharmacy at the University of Minnesota was invited by Prof. Imming as a visiting professor at MLU. In addition to research work in the laboratory, he will give lectures on green chemistry and his research as well as lectures and seminars for pharmacy students. He is internationally known for his work on active ingredients against tuberculosis and is Editor-in-Chief of the journal ACS Infectious Diseases.

www.pharmazeutische-zeitung.de/theophyllin-als-hoffnungstraeger-139432